Insider · CIK 0001968793
Sudarshan Hebbar
Files at CALC (CalciMedica, Inc.). First filing Aug 18, 2025, latest Aug 21, 2025.
Sudarshan Hebbar files SEC Form 4 as officer at CALC (CalciMedica, Inc.). Since Aug 18, 2025, Sudarshan Hebbar has reported 2 open-market buys worth $43k and 0 open-market sells worth $0, the latest filed on Aug 21, 2025.
A track record needs three past buys with six months of prices behind them; Sudarshan Hebbar has 0, so none is measured yet.
The newest scored trade: bought $27k of CALC on Aug 19, 2025, filed Aug 21, 2025, scored 44 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CALC: CalciMedica, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | CalciMedica, Inc. | $27k 9,563 shares | +18% | +94% from low-44% from high | |
| 34Weak | CalciMedica, Inc. | $16k 5,976 shares | +13% | +83% from low-48% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +180,000 | $0.00 | $0 | 180,000 | 15 d ago |
| Jun 25, 2026 | CALC CalciMedica, Inc. | AGrant or award Common Stock | +124,486 | $0.80 | $100k | 186,025 | Jun 29, 2026 |
| Apr 5, 2025 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +91,173 | $0.00 | $0 | 91,173 | Apr 7, 2026 |
| Aug 19, 2025 | CALC CalciMedica, Inc. | POpen-market purchase Common Stock | +9,563 | $2.82 | $27k | 61,539 | Aug 21, 2025 |
| Aug 14, 2025 | CALC CalciMedica, Inc. | POpen-market purchase Common Stock | +1,584 | $2.59 | $4,095 | 47,584 | Aug 18, 2025 |
| Aug 15, 2025 | CALC CalciMedica, Inc. | POpen-market purchase Common Stock | +4,392 | $2.79 | $12k | 51,976 | Aug 18, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +83,300 | $0.00 | $0 | 83,300 | Jun 26, 2025 |
| Apr 23, 2025 | CALC CalciMedica, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Apr 25, 2025 |
Questions about Sudarshan Hebbar
Answered from the filings on this page, as of the latest one.
Is Sudarshan Hebbar buying or selling?
Not in the last 12 months. Sudarshan Hebbar's latest open-market trade on SEC Form 4 was bought $27k of CALC on Aug 19, 2025.
How did Sudarshan Hebbar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sudarshan Hebbar has 0.
Where does Sudarshan Hebbar file Form 4?
Sudarshan Hebbar has filed Form 4 at CALC (CalciMedica, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.